MCAC Panel Takes "Clinical Common Sense" Approach To Coverage Review
This article was originally published in The Gray Sheet
Executive Summary
HCFA's Medicare Coverage Advisory Committee reached a favorable decision for ambulatory blood pressure monitors (ABPMs) after adopting what it termed a "practical" approach for a technology that is difficult to study in a randomized setting.
You may also be interested in...
Spacelabs Looks To Pending CMS Decision To Boost U.S. ABPM Market
Spacelabs Medical expects a positive upcoming reimbursement decision from CMS in October to boost U.S. sales of its Ultralite ambulatory blood pressure monitor (ABPM).
Spacelabs Looks To Pending CMS Decision To Boost U.S. ABPM Market
Spacelabs Medical expects a positive upcoming reimbursement decision from CMS in October to boost U.S. sales of its Ultralite ambulatory blood pressure monitor (ABPM).
MCAC Amendments Open Up Panel Process, Broaden Scope Of Reviews
Evidence report questions for each Medicare Coverage Advisory Committee panel meeting will be made public much earlier in the review process under guidelines updated by the MCAC Executive Committee at a Feb. 22 meeting in Baltimore.